Back

The impact of renin-angiotensin-aldosterone system dysregulation: how aldosterone synthase inhibition could be a game changer

9 May 2026 (12:00 - 12:05)
Organised by: Logo
Congress Presentation Part of: New frontiers in cardiovascular medicine: SGLT2/aldosterone synthase inhibition in heart failure treatment and prevention Chronic Heart Failure Open Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Biykem Bozkurt

Baylor College of Medicine, Houston (United States of America)

4 More presentations in this session

Presentation thumbnail
Addressing the cardiorenal nexus: multimodal strategies for patients with heart failure and comorbid chronic kidney disease
Doctor J. Nunez Villota (Valencia, ES)
Slides
Presentation thumbnail
Translating science to outcomes: clinical evidence for targeting aldosterone through renin-angiotensin-aldosterone system modulation
Doctor R. Mentz (Durham, US)
Slides
Presentation thumbnail
Intervening early: can we prevent heart failure from the start?
Professor P. Campbell (Newry, GB)
Slides
Presentation thumbnail
Live Q&A and closing remarks
Doctor J. Nunez Villota (Valencia, ES) Professor B. Bozkurt (Houston, US) Professor P. Campbell (Newry, GB) Doctor R. Mentz (Durham, US)
Slides

Access the full session

Session thumbnail
New frontiers in cardiovascular medicine: SGLT2/aldosterone synthase inhibition in heart failure treatment and prevention
Video

The Event

Event poster

Heart Failure 2026

9 May 2026 12:00 CET
You may be interested in
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Nursing and Allied Professions Investigator Award
thumbnail
Congress Session
Which device might help your HFpEF patient?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources